3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
2
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Neoplasm Metastasis
1
Leiomyosarcoma
1
Gastrointestinal Stromal Tumors
1
Interventions
Ifosfamide
6
Doxorubicin
6
Radiotherapy
4
Filgrastim
2
Etoposide
2
trofosfamide
1
pegfilgrastim
1
indolepropanol phosphate
1
fludarabine
1
anlotinib
1
Watchful Waiting
1
Tablets
1
Rosuvastatin Calcium
1
Radiotherapy, Conformal
1
Observation
1
Midazolam
1
Idarubicin
1
Digoxin
1
Diathermy
1
Dacarbazine
1
Cyclophosphamide
1
Combined Modality Therapy
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma, Synovial
×
Midazolam
×
Clear all
NCT03016819
2026-02-25
APROMISS
Advenchen Laboratories, LLC
Phase 3
Recruiting
325 enrolled